• N/A
    Market Cap
  • -96.50%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
Income Statement
Total Operating Revenue
155,000
+453.57%
28,000
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
Gross Profit
155,000
+453.57%
28,000
N/A
Sales and Marketing Expense
154,000
+1,084.62%
13,000
N/A
Research and Development Expense
-7.1M
+22.79%
-5.8M
N/A
Depreciation and Amortization Expense
14,000
-44.00%
25,000
N/A
Total Operating Expenses
11.6M
-7.47%
12.6M
N/A
Operating Profit
-11.6M
-7.47%
-12.6M
N/A
Interest Income
155,000
+453.57%
28,000
N/A
Interest Expense
-142,000
+14,100.00%
-1,000
N/A
Interest Income and Expense and Net
13,000
-51.85%
27,000
N/A
Total Nonoperating Income and Expense
277,000
-92.97%
3.9M
N/A
Income before Taxes
-11.9M
-27.86%
-16.5M
N/A
Income Taxes
3,000
-70.00%
10,000
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
Net Income
-11.9M
-27.89%
-16.5M
N/A
Net Income from Continuing Operations Applicable to Common
-11.9M
-27.86%
-16.5M
N/A
Basic EPS and Net Income
8.96
-66.01%
26.36
N/A
Diluted EPS and Net Income
8.96
-66.01%
26.36
N/A
Basic Weighted Average Shares
1.3M
+113.12%
623,846
N/A
Diluted Weighted Average Shares
1.3M
+113.12%
623,846
N/A
Balance Sheet
Cash and Cash Equivalents
6.0M
+404.72%
1.2M
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
6.0M
+404.72%
1.2M
N/A
Total Current Assets
6.6M
+194.98%
2.3M
N/A
Accumulated Depreciation
80,000
+19.40%
67,000
N/A
Property and Plant and Equipment and Net
25,000
-16.67%
30,000
N/A
Total Long-Term Assets
578,000
-5.71%
613,000
N/A
Total Assets
7.2M
+152.01%
2.9M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
Total Short-Term Debt
86,000
-9.47%
95,000
N/A
Total Current Liabilities
2.8M
-21.71%
3.5M
N/A
Total Long-Term Debt
1.6M
+156,700.00%
1,000
N/A
Total Long-Term Liabilities
1.9M
-44.31%
3.3M
N/A
Total Liabilities
4.6M
-32.69%
6.9M
N/A
Retained Earnings
-55.2M
+27.54%
-43.3M
N/A
Total Stockholders Equity
2.6M
+165.25%
-4.0M
N/A
Total Shares Outstanding
3.1B
+69.13%
1.8B
N/A
Cash Flow
Cash from Operating Activities
-10.8M
+28.86%
-8.4M
N/A
Capital Expenditures
9,000
-59.09%
22,000
N/A
Cash from Investing Activities
-14,000
-36.36%
-22,000
N/A
Dividends Paid
N/A
N/A
N/A
N/A
Cash from Financing Activities
15.6M
+206.43%
5.1M
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
Operating Margin
-7,504.52%
N/A
N/A
N/A
Return on Assets
-236.40%
N/A
N/A
N/A
Return on Equity
1,718.90%
N/A
N/A
N/A
Revenue Growth
453.57%
N/A
N/A
N/A
Current Ratio
2.41
N/A
N/A
N/A
Cash Ratio
2.17
N/A
N/A
N/A
Debt-to-Equity Ratio
0.64
N/A
N/A
N/A
Debt-to-Assets Ratio
0.23
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow